Oaktree Acquisition Corp. III Life Sciences financial data

Symbol
OACC, OACCU, OACCW on Nasdaq
Location
333 South Grand Avenue, 28 Th Floor, Los Angeles, CA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Income Statement

Label TTM Value / Value Unit Change %
Operating Income (Loss) -270K USD
Nonoperating Income (Expense) 2.14M USD
Net Income (Loss) Attributable to Parent 1.87M USD

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.39M USD
Assets, Current 1.56M USD
Assets 199M USD
Liabilities, Current 1.12M USD
Liabilities 8.14M USD
Retained Earnings (Accumulated Deficit) -6.54M USD
Stockholders' Equity Attributable to Parent -6.54M USD
Liabilities and Equity 199M USD

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -75.6K USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1.39M USD
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares
Additional Paid in Capital 0 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares